过敏原质控品Allergens Rast scores
过敏原质控品Allergens Rast scores

美国Seracare过敏原质控品Allergens Rast scores

参考价: 面议

具体成交价以合同协议为准
2022-11-29 20:36:29
664
产品属性
关闭
广州健仑生物科技有限公司

广州健仑生物科技有限公司

初级会员12
收藏

组合推荐相似产品

产品简介

美国Seracare过敏原质控品Allergens Rast scores 抗原抗体 标准品 需要了解美国Seracare的产品可以,本质控品由广州健仑生物供应。

详细介绍

美国Seracare过敏原质控品Allergens Rast scores

广州健仑生物科技有限公司

广州健仑长期供应各种生物原料,主要代理品牌:美国Seracare、西班牙Certest、美国Fuller等等。

主要产品包括各种标准品、阳性对照品、单克隆抗原抗体。

其中常见的有:弓形虫病、西尼罗河病毒、类风湿因子、疟疾、麻疹、莱姆病、百日咳杆菌、大肠杆菌、鼠伤寒沙门氏菌、李斯特菌等阳性对照品。

美国Seracare过敏原质控品Allergens Rast scores

我司还提供其它进口或国产试剂盒:登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

Seracare产品介绍】

编号

英文名称

中文名称

JL-FA-01

Amebiasis (AME)

阿米巴病

JL-FA-02

Allergens, Rast scores

过敏原,放射性过敏原吸收实验。指对特定的人群引起免疫反应或者过敏反应的食品中的蛋白质

JL-FA-03

Allergens, Rast scores negative

过敏原,放射性过敏原吸收实验阴性

JL-FA-04

Anti-cyclic citrullinated peptide Antibody (CCP) Arthritis

抗环瓜氨酸肽抗体

JL-FA-05

ASCA Saccharomyces Cerevi

人抗酿酒酵母抗体(ASCA)

JL-FA-06

Aspergillis

麴菌病

JL-FA-07

Beta 2 Glycoprotein

β2糖蛋白

JL-FA-08

Beta 2 Glycoprotein  IgM

β2糖蛋白 IGM

JL-FA-09

Bordela Pertussis

百日咳杆菌

JL-FA-10

Bordela Pertussis IgM

百日咳杆菌 IGM

JL-FA-11

C-ANCA

C-抗中性粒细胞胞浆抗体(ANCA)

JL-FA-12

Cardiolipin

心肌磷脂

JL-FA-13

Cardiolipin IgA

心肌磷脂 IGA

JL-FA-14

Cardiolipin IgG

心肌磷脂 IGG

JL-FA-15

Cardiolipin IgM

心肌磷脂 IGM

JL-FA-16

Cerebral Spinal Fluid

脑脊髓液

JL-FA-17

Chagas

恰加斯病/南美锥虫

JL-FA-18

Chlamydia

衣原体

JL-FA-19

Chlamydia IgA

衣原体IGA

JL-FA-20

Chlamydia IgG

衣原体IGG

JL-FA-21

Chlamydia IgM

衣原体IGM

JL-FA-22

Chlamydia Neg

衣原体阴性

JL-FA-23

Clotting Factor C3

凝固因子C3

JL-FA-24

Clotting Factor C4

凝固因子C4

JL-FA-25

Coccidiodes

球孢菌

JL-FA-26

Cytomegalovirus (CMV) Neg

巨细胞病毒抗体阴性

JL-FA-27

CMV IgG

巨细胞病毒 IGG阳性

JL-FA-28

CMV IgM VCA

巨细胞病毒 IGM 阳性

JL-FA-29

C-Reactive Protein (CRP)

C-反应蛋白质

JL-FA-30

Dengue Fever

登革热

JL-FA-31

Dengue Fever IgM

登革热 IGM

JL-FA-32

DS (Double Stranded) DNA

双链脱氧核糖核酸

JL-FA-33

EBNA (Epstein-Barr nuclear antigen) IgG

EB病毒核抗原 IGG

JL-FA-34

EBNA (Epstein-Barr nuclear antigen) IgM

EB病毒核抗原 IGM

JL-FA-35

Epstein Barr Virus (EBV) Negative Plasma

EB病毒阴性血浆

JL-FA-36

Epstein Barr Virus (EBV) EA IgM

EB病毒早期抗原 IGM

JL-FA-37

Epstein Barr Virus (EBV) VCA IgM

EB病毒壳蛋白  IGM

JL-FA-38

Epstein Barr Virus (EBV) EA IgG

EB病毒早期抗原 IGG

JL-FA-39

EMA (Endomysial Antibodies)

肌内膜

JL-FA-40

Gliadin

麸蛋白,麦醇溶蛋白,麦胶蛋白

JL-FA-41

Gliadin IgG

麦醇溶蛋白  IGG

JL-FA-42

Gliadin IgA

麦醇溶蛋白 IGA

JL-FA-43

Glomerular Basement Membrane (GBMA)

肾小球基底膜病

JL-FA-44

Helicobacter pylori IgA

幽门螺旋杆菌IGA

JL-FA-45

Helicobacter pylori IgG

幽门螺旋杆菌IGG

JL-FA-46

Helicobacter pylori IgM

幽门螺旋杆菌IGM

JL-FA-47

Helicobacter pylori Negative

幽门螺旋杆菌阴性

JL-FA-48

Helicobacter pylori Positive Plasma

幽门螺旋杆菌阴性血浆

JL-FA-49

Hepatitis A Virus (HAV) Pos. Plasma

甲型肝炎病毒阳性血浆

JL-FA-50

Hepatitis A Virus (HAV) IgM

甲型肝炎病毒IGM

JL-FA-51

Hepatitis B Core (HBc) IgG

乙型肝炎病毒核心 IGG

JL-FA-52

Hepatitis B Core (HBc) IgM

乙型肝炎病毒核心 IGM

JL-FA-53

Anti Hbe (Antibody to HBV antigen)

乙肝抗体

JL-FA-54

Hepatitis Delta Virus

丁型肝炎病毒

JL-FA-55

HBeAg (HBV e antigen)

乙肝 E抗原

JL-FA-56

anti-HBs (HBV surface antibody)

乙肝表面抗体

JL-FA-57

Hepatitis B (HBsAg) "Chronic"

乙型肝炎(乙肝表面抗原)“慢性病

JL-FA-58

HBsAg (HBV surface antigen) Serum

乙肝表面抗原血清

JL-FA-59

HBsAg (AD)

乙肝表面抗原(AD)

JL-FA-60

HBsAg (AY)

乙肝表面抗原(AY)

JL-FA-61

HBV Positive Plasma

乙肝阳性血浆

JL-FA-62

HBV DNA Plasma

乙肝DNA血浆

JL-FA-63

HBV DNA Serum

乙肝DNA血清

JL-FA-64

HBV DNA type A

 A型 乙肝DNA

JL-FA-65

HBV DNA type B

 B型 乙肝DNA

JL-FA-66

HBV DNA type C

 C型 乙肝DNA

JL-FA-67

HBV DNA type D

 D型 乙肝DNA

JL-FA-68

HBV DNA type E

 E型 乙肝DNA

JL-FA-69

HBV DNA type F

 F型 乙肝DNA

JL-FA-70

HBV Antibody HCV Antibody Plasma CO-INFECTED

乙肝和丙肝联合感染血浆

JL-FA-71

HCV (Hepatitis C Virus) Antibody

丙型肝炎抗体

JL-FA-72

HCV Core Antigen Positive

丙肝核心抗原 阳性

JL-FA-73

HCV RNA PLASMA Genotype 1

基因1型丙肝RNA 血浆

JL-FA-74

HCV RNA PLASMA Genotype 2

基因2型丙肝RNA 血浆

JL-FA-75

HCV RNA PLASMA Genotype 3

基因3型丙肝RNA 血浆

JL-FA-76

HCV RNA PLASMA Genotype 4

基因4型丙肝RNA 血浆

JL-FA-77

HCV RNA PLASMA Genotype 5

基因5型丙肝RNA 血浆

JL-FA-78

HCV RNA PLASMA Genotype 6

基因6型丙肝RNA 血浆

JL-FA-79

HCV Riba single band

丙肝免疫印迹单波段

JL-FA-80

HCV RIBA Pos. (multiple bands)

丙肝免疫印迹阳性多波段

JL-FA-81

HCV Negative

丙肝阴性

JL-FA-82

HCV RNA Pos (quantitative)

丙肝RNA阳性(定量)

JL-FA-83

Hepatitis E

戊型肝炎

JL-FA-84

Herpes Simplex Virus (HSV)1/2 Positive Plasma

单纯性疱疹病毒1/2阳性血浆

JL-FA-85

Herpes Simplex Virus (HSV) 1 Negative Plasma

单纯性疱疹病毒1 阴性血浆

JL-FA-86

Herpes Simplex Virus (HSV) 1 IgG

单纯性疱疹病毒1 IGG

JL-FA-87

Herpes Simplex Virus (HSV 1) IgM

单纯性疱疹病毒1 IGM

JL-FA-88

Herpes Simplex Virus (HSV) 2 IgG

单纯性疱疹病毒2 IGG

JL-FA-89

Herpes Simplex Virus (HSV) 2 IgM

单纯性疱疹病毒2 IGG

JL-FA-90

Histone

组蛋白

JL-FA-91

Human Anti Mouse Ab (HAMA)

人抗鼠抗体

JL-FA-92

Human immunodeficiency virus (HIV) 1 Neg

HIV  I 阴性

JL-FA-93

anti Human immunodeficiency virus (HIV) 1 Plasma

抗HIV  I 血浆

JL-FA-94

anti Human immunodeficiency virus (HIV) 1 Serum

抗HIV  I 血清

JL-FA-95

anti Human immunodeficiency virus (HIV) 2 Western Blot Tested

抗HIV  2 免疫印迹

JL-FA-96

anti Human immunodeficiency virus (HIV) 1/2 2 HIV (+)

抗HIV 1/2 2  HIV阳性

JL-FA-97

Human immunodeficiency virus (HIV) Ag

HIV抗原

JL-FA-98

HIV RNA (quantitative) Plasma

HIV RNA 定量血浆

JL-FA-99

HIV RNA (quantitative) Serum

HIV RNA 定量血清

JL-FA-100

HIV1 Subtype A

HIV1  亚型A

JL-FA-101

HIV1 Subtype B

HIV1  亚型B

JL-FA-102

HIV1 Subtype C

HIV1  亚型C

JL-FA-103

HIV1 Subtype D

HIV1  亚型D

JL-FA-104

HIV1 Subtype E

HIV1  亚型E

JL-FA-105

HIV1 Subtype F

HIV1  亚型F

JL-FA-106

HIV1 Subtype G

HIV1  亚型G

JL-FA-107

HIV1 Subtype H

HIV1  亚型H

JL-FA-108

HIV1 Subtype J

HIV1  亚型J

JL-FA-109

HIV1 Subtype K

HIV1  亚型K

JL-FA-110

HIV1 Group O

HIV1  亚型O

JL-FA-111

Human immunodeficiency virus (HIV) 2 Antibody Plasma

HIV 2 抗体血浆

JL-FA-112

Human immunodeficiency virus (HIV) 2 Antibody Serum

HIV 2 抗体血清

JL-FA-113

HPV (Human Papiloma Virus) Negative

人乳状瘤病毒HPV阴性

JL-FA-114

HPV (Human Papiloma Virus) Positive

人乳状瘤病毒HPV阳性

JL-FA-115

Human immunodeficiency virus (HIV) Antibody HCV Antibody Plasma COINFECTED

HIV 抗体  HCV

JL-FA-116

Human T-cell Lymphotropic Virus (HTLV) I/II

人嗜T淋巴细胞病毒(HTLV) I/II

JL-FA-117

Human T-cell Lymphotropic Virus (HTLV) I

人嗜T淋巴细胞病毒(HTLV) I

JL-FA-118

Human T-cell Lymphotropic Virus (HTLV) II

人嗜T淋巴细胞病毒(HTLV) II

JL-FA-119

Jo-1

多发性肌炎抗原JO-1

JL-FA-120

IgE < 5,000 Ku/L

IgE < 5,000 Ku/L

JL-FA-121

Legionella

军团杆菌属

JL-FA-122

Leptospira

军团杆菌属

JL-FA-123

Lyme Disease

莱姆(氏)病:蜱传播的全身性疾病,常在夏季发生

JL-FA-124

Lyme IgG

莱姆(氏)病 IGG

JL-FA-125

Lyme IgM

莱姆(氏)病 IGM

JL-FA-126

Lyme Disease Neg

莱姆(氏)病 阴性

JL-FA-127

Malaria

疟疾

JL-FA-128

Mononucleosis (infectious)

单核细胞增多症(有传染性的)

JL-FA-129

Mononucleosis Negative

单核细胞增多症阴性

JL-FA-130

Measles Negative

麻疹 阴性

JL-FA-131

Measles IgG

麻疹 IGG

JL-FA-132

Measles IgM

麻疹  IGM

JL-FA-133

Microsomal Anti-thyroid peroxidase antibody (TPO) Positive Plasma Standard Titer (typically 1,000-3,000 IU/mL)

微粒体抗甲状腺过氧化物酶抗体

JL-FA-134

Microsomal Anti-thyroid peroxidase antibody (TPO) Negative Plasma

微粒体抗甲状腺过氧化物酶抗体

JL-FA-135

Anti-mitochondrial antibody (AMA)

抗线粒体抗体

JL-FA-136

Multiple Sclerosis

多发性硬化症

JL-FA-137

Mumps IgG

流行性腮腺炎 IGG

JL-FA-138

Mumps Ab IgM

流行性腮腺炎抗体 IGM

JL-FA-139

Mumps Antibody Negative Plasma

流行性腮腺炎抗体阴性血浆

JL-FA-140

Mumps Antibody Negative Serum

流行性腮腺炎抗体阴性血清

JL-FA-141

Myeloma Plasma

骨髓瘤血浆

JL-FA-142

Myeloma IgA

骨髓瘤IGA

JL-FA-143

Myeloma IgE

骨髓瘤IGE

JL-FA-144

Myeloma IgG

骨髓瘤IGG

JL-FA-145

Myeloma IgM

骨髓瘤IGM

JL-FA-146

Mycoplasma

支原体

JL-FA-147

Mycoplasma Negative

支原体阴性

JL-FA-148

Mycoplasma IgG

支原体IGG

JL-FA-149

Mycoplasma IgM

支原体IGM

JL-FA-150

Mycoplasma PCR

支原体PCR

JL-FA-151

Normal Human Plasma

正常人血浆

JL-FA-152

Normal Human Serum

正常人血清

JL-FA-153

Nuclear Antibody Centromere

核抗体着丝粒

JL-FA-154

Nuclear Antibody, Speckled ANA

核抗体,斑点抗核抗体

JL-FA-155

Nuclear Antibody, Nucleolar ANA

核抗体,核仁抗核抗体

JL-FA-156

Nuclear Antibody, Homogeneous ANA

核抗体,同质抗核抗体

JL-FA-157

Nuclear Antiobody, Speckled. (ANA) Negative

核抗体,斑点。抗核抗体阴性

JL-FA-158

P-ANCA (associated neutrophil cytoplasmic antibodies)

相关的嗜中性粒细胞胞浆抗体

JL-FA-159

Parietal Cell Antibody (PCA)

胃)壁细胞抗体

JL-FA-160

Parvo positive plasma

细小病毒阳性血浆

JL-FA-161

Parvo IgM

细小病毒 IGM

JL-FA-162

Parvo IgG

细小病毒 IGG

JL-FA-163

Parvo Negative Plasma

细小病毒阴性血浆

JL-FA-164

Parvo DNA positive

细小病毒 DNA 阳性

JL-FA-165

Phospholipid Positive Plasma

磷脂阳性血浆

JL-FA-166

Prothrombin

凝血酶原,凝血因子

JL-FA-167

Rheumatoid Factor (RF) <1000 IU/mL

类风湿因子<1000 IU/mL

JL-FA-168

Rheumatoid Factor (RF) 1001-2000 IU/mL

类风湿因子1001-2000 IU/mL

JL-FA-169

Rheumatoid Factor (RF) 2001-4000 IU/mL

类风湿因子 2001-4000 IU/mL

JL-FA-170

Rheumatoid Factor (RF) 4001-5000 IU/mL

类风湿因子 4001-5000 IU/mL

JL-FA-171

Rheumatoid Factor (RF) >5000 IU/mL

类风湿因子>5000 IU/mL

JL-FA-172

Ribonucleoprotein (RNP) Positive

核糖核蛋白阳性

JL-FA-173

Rubella Chimeric

风疹

JL-FA-174

Rubella Negative

风疹阴性

JL-FA-175

Rubella IgG

风疹IGG

JL-FA-176

Rubella IgM

风疹IGM

JL-FA-177

Rubeola Negative Plasma

风疹阴性血浆

JL-FA-178

Rubeola IgG

风疹IGG

JL-FA-179

Scleroderma (Scl-70) Pos

胶原沉着病,硬皮病,硬皮症 阳性

JL-FA-180

Scleroderma (Scl-70) Negative

硬皮病阴性

JL-FA-181

Sickle Cell Fresh Whole Blood

镰刀形红细胞新鲜全血

JL-FA-182

Smith (SM)

抗Smith抗体阳性血清(SLE的特征性抗体)

JL-FA-183

SMITH RNP

抗RNP抗体阳性血清(SLE的特征性抗体)

JL-FA-184

Smooth Muscle (ASMA)

抗平滑肌抗体阳性血清

JL-FA-185

Sjogren syndrome antigen A (SSA) Positive

舍格伦综合征或干燥综合征抗原A 阳性

JL-FA-186

Sjogren syndrome antigen B (SSB) Positive

舍格伦综合征抗原B 阳性

JL-FA-187

Sjogren syndrome antigen B (SSB) Negative

舍格伦综合征抗原B阴性

JL-FA-188

Streptolysin O Ab (ASO)

链球菌溶血素O抗体

JL-FA-189

Syphilis (RPR - Rapid Plasma Reagin) Positive Plasma

梅毒(梅毒-快速血浆反应)阳性血浆

JL-FA-190

Syphilis (RPR - Rapid Plasma Reagin) Negative Plasma

梅毒(梅毒-快速血浆反应)阴性血浆

JL-FA-191

Syphilis/ATA/T. pallidum IgG

梅毒ATA/T,苍白球IGG

JL-FA-192

Syphilis/ATA/T. pallidum IgM

梅毒ATA/T,苍白球IGM

JL-FA-193

Systemic Lupus Erythematosus (SLE) Positive

全身性红斑狼疮阳性

JL-FA-194

Systemic Lupus Erythematosus (SLE) Negative

全身性红斑狼疮阴性

JL-FA-195

TG/TPO Positive (Standard Titer 1,000 - 3000 IU/mL)

甲状腺球蛋白/甲状腺过氧化物酶阳性

JL-FA-196

TG/TPO Negative

甲状腺球蛋白/甲状腺过氧化物酶阴性

JL-FA-197

TTG (Tissue Transglutaminase)

组织转谷氨酰胺酶

JL-FA-198

TTG (Tissue Transglutaminase) IgA

组织转谷氨酰胺酶 IGA

JL-FA-199

ToRCH (Toxo, Rubella, CMV, HSV) Positive

优生优育(弓形虫,风疹,巨细胞,单胞)阳性

JL-FA-200

ToRCH (Toxo, Rubella, CMV, HSV) Negative

优生优育(弓形虫,风疹,巨细胞,单胞)阴性

JL-FA-201

Toxoplasmosis (Toxo)

弓形虫病

JL-FA-202

Toxoplasmosis (Toxo) IgG

弓形虫病IGG

JL-FA-203

Toxoplasmosis (Toxo) IgM

弓形虫病IGM

JL-FA-204

Thyroglobulin (TG) Positive Plasma

甲状腺球蛋白阳性血浆

JL-FA-205

Thyroglobulin (TG) Negative

甲状腺球蛋白阴性

JL-FA-206

Varicella-Zoster Virus (VZV) Negative

水痘-带状疱疹病毒阴性

JL-FA-207

Varicella-Zoster Virus (VZV) IgG

水痘-带状疱疹病毒IGG

JL-FA-208

Varicella-Zoster Virus (VZV) IgM

水痘-带状疱疹病毒IGM

JL-FA-209

West Nile Virus (WNV)

西尼罗河脑炎病毒

JL-FA-210

West Nile Virus (WNV) IgM

西尼罗河脑炎病毒IGM

美国Seracare

该研究小组发现,两种不同的B细胞谱系抗体联手,刺激备受追捧的广谱中和抗体对抗HIV。该研究组由杜克大学艾滋病毒/艾滋病疫苗免疫学,免疫原发现(CHAVI-ID)中心杜克大学人类疫苗研究所的主任巴顿·海恩斯,以及该疫苗研究中心的国家过敏和传染病研究所(NIAID)的主任John Mascola医学博士所的。
海恩斯说,这些可中和多种hiv病毒株的抗体的激活是是一个性疫苗的关键策略。高水平的这种抗体在约20%的艾滋病毒感染者中产生。
去年,该研究组在Nature杂志上*描述广谱中和抗体(bnAbs)的共同进化,以及病毒激活感染者内的这些抗体。现在,同样的研究小组报告了患者体内的免疫系统的B细胞学会中和许多种HIV病毒株的确切机制。
在这项新研究中,科学家惊讶地发现,一个辅助的中和抗体组和交叉反应中和抗体合作,产生一套强而有力的广谱中和抗体。其他辅助谱系包含与导致感染的病毒中和的抗体。
这种抗体靶向病毒的外膜区域,该区域也能够与广谱中和抗体结合。在这样做时,辅助谱系抗体选择具有较强能力的病毒刺激广谱中和抗体系。
因此,一组抗体选择一组病毒逃逸突变体“教导”广谱中和抗体系如何中和HIV变种。科学家推测,这个过程会反复发生在整个感染中,导致中和多种HIV毒株的抗体谱的产生。
“一个bnAb谱系的成熟可以通过辅助谱系来提升的这一发现,对艾滋病疫苗的发展有着重要的影响,”文章*作者、杜克大学人类疫苗研究所Feng Gao博士说。“来自于初始传播/原始病毒的免疫原的反复免疫,以及逃避变体与bnAb谱系具有更高的结合能力,都可能需要激活bnAbs。”
“下一步是要在能够产生广谱中和抗体的其他个体中进行类似的研究,并确定诱导这种抗体的其他特异性是一个普遍的机制,” 海恩斯说。“然后,zui终证明,这一发现可用于设计可诱导广谱中和抗体的免疫原。”
利用这项研究的结果,该研究模仿自然感染艾滋病毒的光谱中和抗体发展,已经设计出一种疫苗免疫原,有选择性地触发产生抗体的B细胞进行合作,产生广谱中和抗体。
随着癌症的发育,正常的血液供给慢慢不能满足其需求,因此过度生长的肿瘤组织吸收的氧气量就会比正常组织少,这种低氧环境称之为缺氧状态,缺氧状态往往和不同类型的恶性肿瘤的发生相关。
这项研究中研究人员利用结肠癌组织进行研究发现,缺氧条件可以诱发关键的肿瘤抑制基因MLH1发生沉默;与此同时研究人员也发现了一种名为LSD1的酶类,这种酶是一种赖氨酸特殊的脱甲基酶,酶类LSD1连同MLH1都可以作为逆转或者阻断沉默过程的靶点;由于LSD1是一种特殊酶类,因此科学家们可以利用小分子对其产生的靶向作用来抑制其活性。

美国Seracare

我司还提供其它进口或国产试剂盒:登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、食品安全、化妆品检测、药物滥用检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的产品及服务请扫描下方二维码:

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

The team found that two different B-cell lineage antibodies work in tandem to stimulate the highly sought-after broad-spectrum neutralizing antibodies against HIV. The research team was led by Barton Haynes, director of the Duke University HIV Vaccine Immunology, Duke University Center for Human Immunization Discovery (CHAVI-ID) Center at Duke University, and the National Allergy and Infectious Diseases Led by John Mascola, MD, director of the Institute (NIAID).
Haynes said the activation of antibodies that neutralize multiple hiv strains is a key strategy for a global vaccine. High levels of this antibody are produced in about 20% of HIV-infected individuals.
Last year, the team first described in Nature the co-evolution of broad-spectrum neutralizing antibodies (bnAbs), and the virus activates these antibodies in infected individuals. The same team now reports on the exact mechanism by which B cells in the immune system in a patient learn to neutralize many types of HIV strains.
In this new study, scientists were surprised to find that a co-neutralizing antibody group works with cross-reacting neutralizing antibodies to produce a robust set of broad-spectrum neutralizing antibodies. Other accessory lineages contain antibodies that neutralize the virus that causes the infection.
This antibody targets the outer membrane region of the virus, which is also capable of binding to a broad spectrum of neutralizing antibodies. In doing so, the accessory lineage antibody selects a more competent virus to stimulate the broad-spectrum neutralizing antibody system.
Thus, a panel of antibodies selected from a group of virus escape mutants "teaches" how broad-spectrum neutralizing antigens neutralize HIV variants. Scientists speculate that this process occurs repeatedly throughout the infection, resulting in the production of antibody profiles that neutralize multiple HIV strains.
"The discovery that the maturation of a bnAb lineage can be enhanced by ancillary lineages has a significant impact on the development of an AIDS vaccine," said lead author Feng Gao, PhD, of Duke University's Human Vaccine Institute. "Repeated immunizations from immunogens that originate / originate the virus, and the ability of escape variants to bind to the bnAb lineage, may require the activation of bnAbs."
"The next step is to do similar research in other individuals that are capable of producing broad-spectrum neutralizing antibodies and to establish that other specificities that induce such antibodies are a common mechanism," Haines said. "And then it turns out that this finding can be used to design immunogens that induce broad-spectrum neutralizing antibodies."
Using the results of this study, which mimicked the development of neutralizing antibodies in naturally infected HIV, a vaccine immunogen has been designed that selectively triggers the production of antibody-producing B cells to produce broad-spectrum neutralizing antibodies.
With the development of cancer, the normal blood supply slowly can not meet their needs, so excessive growth of tumor tissue to absorb oxygen than the normal tissue less, this hypoxic environment called hypoxia, hypoxia often And different types of malignancies related to the occurrence.
In this study, researchers using colon cancer tissue research found that hypoxia can induce key tumor suppressor gene MLH1 silence; at the same time researchers also found a class called LSD1 enzymes, this enzyme is a Species of lysine-specific demethylase, enzymes LSD1 together with MLH1 can be used as a reversal or block the target of the process of silencing; because LSD1 is a special enzyme, so scientists can use small molecules on their target To act to inhibit its activity.

上一篇:黄曲霉毒素B1检测卡的工作原理和注意事项 下一篇:黄曲霉毒素B1检测卡的实验步骤
热线电话 在线询价
提示

请选择您要拨打的电话: